131TiP A phase I–III platform study evaluating the safety and efficacy of multiple therapies in patients (pts) with biomarker-defined locally advanced, unresectable stage III non-small cell lung cancer (NSCLC)

Subjects

Subjects :

Pulmonary and Respiratory Medicine
Oncology

Details

ISSN :

15560864

Volume :

18

Database :

OpenAIRE

Journal :

Journal of Thoracic Oncology

Accession number :

edsair.doi...........f6d22b4a493d2cf8fd16fd5c55f0efec

Full Text :

https://doi.org/10.1016/s1556-0864(23)00386-6